Watch live: Biden announces massive new aid package for Ukraine

Watch live: Biden announces massive new aid package for Ukraine


[The stream is slated to start at 9:45 a.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden will announce a new military aid package to Ukraine, which is expected to look similar to the $800 aid million package the U.S. released a week ago.

The package comes as Russia begins an offensive to seize the Donbas region that many analysts believe will be a decisive phase in its unprovoked invasion of Ukraine.

After failing to take Kyiv in a blitzkrieg early in the war, Russia downsized its intent, announcing that it sought only to seize the eastern regions of the country. In recent weeks, Russia has amassed more than 50,000 troops in or near occupied regions of eastern Ukraine.

In order to fend off the Russian assault, Ukrainian troops will need a massive supply of heavy weapons, which the United States is providing in aid packages like the one today.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More